Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Shaare Zedek Medical Center |
---|---|
Information provided by: | Shaare Zedek Medical Center |
ClinicalTrials.gov Identifier: | NCT00446537 |
Skill acquisition refers to the process of improvement of performance following practice experience. This process is the basis for generation of a long-lasting memory. Individuals with Attention Deficit Hyperactivity Disorder (ADHD) have been shown to be impaired on some performance aspects of previously learned skills, an impairment that is often ameliorated, at least temporarily, by psychostimulant medication (the standard therapy in ADHD). The proposed study aims to define the course of learning and of generation of long-term memory consolidation in individuals with ADHD, and to essay the effectiveness of psychostimulant medication on both the learning and retention of the skills.
Condition | Intervention | Phase |
---|---|---|
Attention Deficit Hyperactivity Disorder |
Procedure: Methylphenidate |
Phase 0 |
Study Type: | Interventional |
Study Design: | Randomized, Double-Blind, Placebo Control, Crossover Assignment |
Ages Eligible for Study: | 12 Years to 50 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Contact: Esther Adi-Japha, PhD | 972-3-5318704 | japhae@mail.biu.ac.il |
Israel | |
Neuropediatric Unit | |
Jerusalem, Israel, 91031 |
Principal Investigator: | Esther Adi-Japha, PhD | Bar-Ilan University, Israel |
Study Chair: | Ruth Shalev, MD | Shaare Zedek Medial Center |
Study ID Numbers: | 240446 |
Study First Received: | March 11, 2007 |
Last Updated: | March 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00446537 |
Health Authority: | Israel: Ethics Commission |
Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate |
Signs and Symptoms Dopamine Attention Deficit Disorder with Hyperactivity Mental Disorders Mental Disorders Diagnosed in Childhood |
Methylphenidate Attention Deficit and Disruptive Behavior Disorders Neurologic Manifestations Hyperkinesis Dyskinesias |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Therapeutic Uses Physiological Effects of Drugs |
Nervous System Diseases Central Nervous System Stimulants Dopamine Agents Central Nervous System Agents Pharmacologic Actions |